Effects of  -methyltyrosine on the cerebrospinal fluid content of HVA and 5-HIAA in man.
D002555:Cerebrospinal Fluid / Q000032:analysis / Q000187:drug effects*; D003863:Depression / Q000134:cerebrospinal fluid; D006801:Humans; D006816:Huntington Disease / Q000134:cerebrospinal fluid; D006897:Hydroxyindoleacetic Acid / Q000134:cerebrospinal fluid*; D008781:Methyltyrosines / Q000494:pharmacology*; D010648:Phenylacetates / Q000134:cerebrospinal fluid*; D011618:Psychotic Disorders / Q000134:cerebrospinal fluid; D012559:Schizophrenia / Q000134:cerebrospinal fluid; D013129:Spinal Puncture
D008781:Methyltyrosines; D010648:Phenylacetates; D006897:Hydroxyindoleacetic Acid